PTEN overexpression promotes glioblastoma death through triggering mitochondrial division and inactivating the Akt

Long Bao1, Xiang Li2, Zhixiong Lin1

  • 1Department of Neurosurgery, Beijing Sanbo Brain Hospital, Capital Medical University , Beijing , China.

Insights

PTEN suppresses glioblastoma by activating mitochondrial division via the Akt pathway. This process enhances cancer cell death and offers new therapeutic insights for glioblastoma treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • PTEN is recognized as a tumor suppressor in glioblastoma.
  • Mitochondrial division is implicated in cancer cell death pathways.

Purpose of the Study:

  • To investigate if PTEN inhibits glioblastoma development by regulating mitochondrial division.
  • To elucidate the molecular mechanisms underlying PTEN's function in glioblastoma.

Main Methods:

  • Overexpression of PTEN using adenovirus in U87 glioblastoma cells.
  • Assessment of mitochondrial function and apoptosis via Western blot and immunofluorescence.
  • Inhibition of Akt pathway activation using pathway blockers.

Main Results:

  • PTEN overexpression decreased glioblastoma cell viability and increased apoptosis.
  • PTEN activated mitochondrial apoptosis through induced mitochondrial dysfunction.
  • Drp1-mediated mitochondrial division was essential for PTEN's effects on cell death and mitochondrial damage.
  • PTEN modulated Drp1-related mitochondrial division via the Akt pathway.

Conclusions:

  • PTEN's anticancer effect in glioblastoma relies on activating Drp1-related mitochondrial division through Akt pathway modulation.
  • This study provides novel insights into the tumor-suppressive role of PTEN in glioblastoma.
  • Targeting PTEN and mitochondrial division pathways may offer new therapeutic strategies for glioblastoma.

Related Concept Videos

X-Inactivation01:58

X-Inactivation

The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
41.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.4K
Centrifugation-Assisted Mitochondrial Transfer to Glioblastoma Stem Cells02:13

Centrifugation-Assisted Mitochondrial Transfer to Glioblastoma Stem Cells

In this video, a method is demonstrated to enable the transfer of fluorescently labeled mitochondria into glioblastoma stem cells (GSCs) through centrifugation. The successful uptake and functional integration of the donor mitochondria are confirmed by detecting the fluoresce using confocal...
481
Mitochondrial Ca2+ Retention Capacity Assay and Ca2+-triggered Mitochondrial Swelling Assay05:53

Mitochondrial Ca2+ Retention Capacity Assay and Ca2+-triggered Mitochondrial Swelling Assay

This protocol aims to describe a method to examine the Ca2+ retention capacity and Ca2+- triggered mitochondrial swelling of isolated mitochondria of SH-SY5Y cells...
11.9K
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

The present protocol describes the establishment of a membranous nephropathy (MN) animal model, and how Kemeng Fang's inhibition reduces MN rat podocyte apoptosis by activating the PI3K/AKT signaling...
875
Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

An efficient screening protocol is presented for the identification of small molecules that promote astroglial differentiation in glioblastoma stem cells (GSCs). The assay is based on a stem cell differentiation reporter whereby the expression of the enhanced GFP (eGFP) is driven by the human GFAP promoter.
8.7K